Core Viewpoint - In the context of ongoing adjustments in the Hong Kong stock market, Yidu Tech (02158) has demonstrated its intrinsic value and management confidence through a series of solid buyback operations and significantly improved interim performance [1] Buyback Operations - On December 9, Yidu Tech announced a buyback of 345,000 shares at a price of HKD 5.15 per share, amounting to approximately HKD 1.78 million [1] - The company has implemented buybacks for five consecutive trading days, totaling around 1.42 million shares and exceeding HKD 7.3 million in total buyback amount [1] Financial Performance - For the interim results of the fiscal year 2026, Yidu Tech reported total revenue of RMB 358 million, representing a year-on-year growth of 8.7% [1] - The adjusted EBITDA for existing business reached approximately RMB 54 million, doubling compared to the same period last year, with the company nearing breakeven on the accounting level, achieving this milestone about a year ahead of management's original expectations [1] Market and Industry Trends - According to Guosen Securities, the short-term adjustment in the Hong Kong stock market provides space for recovery in 2026 [1] - The US dollar index is expected to weaken in early 2026, benefiting the valuation recovery of emerging markets [1] - The AI sector remains a key focus for 2026, driven by the need for accelerated domestic hardware production and the anticipation of more AI applications [1] AI Medical Sector - Yidu Tech operates in the AI medical sector, which is one of the most barrier-protected and demand-driven core scenarios in the "AI empowering various industries" trend [1] - The company's medical large model technology has entered a new phase of "multiple blooming and large-scale landing," evidenced by three dimensions: 1. Deep application in well-known hospitals, with the AI middle platform implemented in over 30 top-tier hospitals, achieving nearly 1,000 high-frequency calls per day in a single hospital [1] 2. Significant improvement in the accuracy of the TNM staging assessment intelligent agent for key specialties [1] 3. Integration of expert wisdom through the digital twin of doctors, allowing broader service of clinical experience to patients [1]

进入9月以来,科技牛的强主线行情进入震荡区间,由于前期涨幅较高,防守还是激进成为摆在眼前的现实 问题。 风险提示:投研观点不代表公司立场,不构成投资建议,不代表基金实际持仓或未来投向保证。观点具有时 效性。 方正富邦基金经理吴昊称,目前科技板块的交易拥挤度和融资盘占比已处于历史较高分位,这意味着市场 情绪短期可能过热,容易产生波动。中长期逻辑未变,支撑科技股走强的政策红利、产业周期(特别是AI引 领的变革)、以及资金偏好等核心逻辑并未发生根本性改变。经过短期调整消化估值后,科技股仍有长期 投资价值。 A股在经历过三天的调整后,在科技股的带动下迎来反弹。9月5日,锂电池、光伏、固态电池、储能等板 块涨幅居前,科技股启动全面上攻行情。 我们一直专注于新质生产力范畴之下具备广阔发展空间和成长景气度的细分板块,通过量化的方法在既 定的策略方向和板块之间进行轮动优选。 消息面上,昨日工业和信息化部、市场监督管理总局日前印发《电子信息制造业2025—2026年稳增长行 动方案》,明确2025-2026年,规模以上计算机、通信和其他电子设备制造业增加值平均增速在7%左右,加 上锂电池、光伏及元器件制造等相关领域后电子信息制 ...